MissionIR's  Instablog

VRNG has been running sideways for all of 2013. The price per share looks to be making a slightly higher low within the channel and is approaching the 200-day moving average. The indicators are hinting that this could be the time that the pps tries to make a move above the key moving average.

To view the video chart, visit the following link: http://www.missionir.com/videos.html

Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html

NeoStem is a leader in the emerging cellular therapy industry. The company's business model involves the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing business that provides services to others in the regenerative medicine industry.

The company announced today the extension of intellectual property protection around its lead product candidate, AMR-001, with the notice of a patent allowance in Canada. The Canadian patent protects a chemotactic stem cell product enriched for CD34+ cells that treat injury from acute myocardial infarction. Like most countries, cardiovascular disease is a significant problem in Canada too. Heart disease accounts for over 20% of deaths in Canada.

NeoStem's AMR-001 is a cell therapy in development for treatment of cardiovascular disease. The company is on target to complete enrollment in 2013 in the Phase 2 PreSERVE AMR-001 double-blind clinical trial. The goal of the trial is to investigate the safety and efficacy of AMR-001 in preserving heart function after a heart attack in a particular type of post-heart attack patient. NeoStem is expected to have the first data read-out available six to eight months after the last patient is enrolled.

The granting of the patent by Canada brings the total global patent coverage to ten countries. If the company's trials warrant approval by the FDA, it would position NeoStem to capture a meaningful share of the worldwide acute myocardial infarction market.

For additional information about NeoStem and its lead product candidate, AMR-001, please visit www.neostem.com

Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html

Beaver County in west central Utah is home to the historic Star Mining District. Bolcán Mining was formed to pursue the development of certain mining projects and claims located in the district, in addition to some other parts of Utah. Jameson Stanford Resources acquired Bolcán Mining Corporation in 2012, making Bolcán a wholly owned subsidiary of the company, and giving Jameson certain lode mining claims and mineral leases for Star Mountain. They immediately began work at the Star Mountain/Chopar Mine project site, and are currently doing initial excavation and production at the Chopar Mine site along with exploration and discovery activities at other sites within the Star Mountain project. The company is already working with the first deliveries of copper product.

The Star Mountain project consists of 117 lode mining claims and four metalliferous mineral lease sections located in the Star Mountain range, approximately 12 miles west of Milford, Utah. The Star Mountain project covers nearly 5,000 acres with borders expanding as exploration warrants. Geological analysis and magnetometry studies, along with reverse circulation drilling samples, suggest total inferred reserves at the Star Mountain site of perhaps more than 100,000,000 metric tons of copper ore, plus additional silver, gold, PGM, and base metals.

Jameson Stanford acquires mining claims, mineral leases, and mineral excavation permits with significant economic development potential, and has a high level of confidence in their sites, based upon more than 20 years of experience researching natural mineral resources in the western United States. The company already has customers lined up for their ore production, and expects big things for 2013.

For additional information, visit www.JamesonStanford.com

Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html